Magnolia biondii
Magnolia biondii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Magnolia biondii is a versatile plant species frequently utilized in traditional preparations like shin-i, often involving its flowers or dried tissues. The plant is rich in bioactive essential oils containing key chemical constituents such as 1,8-cineole, alpha-pinene, beta-pinene, and eucalyptol. These compounds allow the plant to function as an effective acaricide and allelochemic, while also demonstrating significant ACE-inhibitor and AChE-inhibitor activities. Due to these pharmacological properties, it is studied for its potential to address health conditions including hypertension, atherosclerosis, allergies, and the common cold. Consequently, Magnolia biondii serves as a significant subject of interest in both medicinal and biochemical research.
- Synonyms
- Yulania Biondii · Magnolia Biondii Var. Axilliflora · 16 more
- Common names
- Not available
- Family
- Magnoliaceae
- Distribution
- Not available
- Plant Parts
- Flower
Classification
Common Names
Magnolia biondii is a beautiful flowering species known by several different names across various languages and regions. In English-speaking contexts, it is frequently referred to by its common name, magnólia Biondiho. Those searching in Russian-speaking areas will often identify the plant as Магнолия Бионди. The species also holds significant cultural recognition in East Asia, where it is called 望春玉兰. Similarly, it is written as 望春玉蘭 to denote its traditional identity.
Sources: Catalogue of Life (COL)
Synonyms
Magnolia biondii is a complex species characterized by a diverse range of botanical synonyms. Scientific literature frequently refers to this plant as Magnolia aulacosperma, reflecting its taxonomic history. Within the species, several distinct varieties have been identified, such as the yellow-flowered Magnolia biondii var. flava. Other documented forms include the unique Magnolia biondii f. purpurascens and the specific Magnolia biondii var. axilliflora. Additionally, the variety known as Magnolia biondii var. latitepala highlights the morphological diversity found within this single plant lineage.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Magnolia biondii is a distinctive member of the kingdom Plantae. Within this vast biological realm, the species belongs to the class Equisetopsida. It is further classified under the order Magnoliales, highlighting its evolutionary lineage. This plant is a proud representative of the family Magnoliaceae. Ultimately, it finds its specific botanical home within the well-known genus Magnolia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Magnoliales |
| Family | Magnoliaceae |
| Genus | Magnolia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Magnolia biondii is a distinguished species primarily found within the Asia-Temperate region. Its natural distribution spans several key areas across China, showcasing a significant geographical presence. Specifically, the plant thrives in the North-Central parts of the country, establishing a strong foothold in these northern climates. It also extends its range into the South-Central territories, adapting well to varying environmental conditions. Furthermore, the species is widely documented throughout the Southeast region of China, completing its extensive regional footprint.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Magnolia biondii is a self-supporting plant that maintains its own structural integrity without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Magnolia biondii is a chemically diverse plant species that possesses a complex profile of essential oil components and bioactive lignans. Gas chromatography-mass spectrometry analysis reveals that its essential oils are characterized by the presence of alpha-pinene, beta-pinene, and eucalyptol. Beyond these volatile terpenes, the plant's chemical makeup includes important secondary metabolites such as eudesmin. Furthermore, the species is associated with the presence of fargesin, a lignan-class phytochemical known for its wide range of pharmacological activities. Together, these constituents highlight the significant biological potential and medicinal importance of Magnolia biondii.
Conditions
Magnolia biondii provides neuroprotective benefits by treating 6-OHDA-induced cell death through its isolated lignan compounds. The species and its related phytochemicals also demonstrate the ability to treat TNF-alpha production through inhibitory effects. Additionally, the medicinal properties of this plant extend to treating allergy in various biological contexts. The pharmacological profile of its active components includes treating anti-inflammatory conditions to reduce systemic irritation. Finally, the plant exhibits biological potential by acting to treat antifeedant requirements.
Preparations
Magnolia biondii is prepared as essential oil and essential oils through processes like steam distillation to facilitate chemical component analysis via GC-MS. The plant is also prepared as dried tissues, which can be identified and authenticated using subtractive diversity array fingerprinting. Additionally, the species is utilized in the preparation of the Chinese crude drug known as shin-i. These various forms allow for the detailed study of volatile compounds and the development of botanical markers.
Parts used
Magnolia biondii is a species that shares botanical characteristics with other members of its genus, specifically regarding the presence of functional flowers. Research into related species like Magnolia fargesii highlights how the flower buds of these plants serve as vital sources for bioactive compounds. For instance, these buds contain unique tetrahydrofuran lignans known as magnones A and B, which exhibit significant antagonistic activity against platelet-activating-factor. Additionally, extracts from the flower buds have been found to yield tiliroside, a compound that demonstrates potent anti-complement activity. Such studies emphasize the pharmacological importance of the floral structures found within this plant group.